Highly elevated systemic inflammation is a strong independent predictor of early mortality in advanced non-small cell lung cancer

Highly elevated systemic inflammation is a strong independent predictor of early mortality in advanced non-small cell lung cancer

Background: Ample evidence support inflammation as a marker of outcome in non-small cell lung cancer (NSCLC). Here we explore the outcome for a subgroup of patients with advanced disease and substantially elevated systemic inflammatory activity. Methods: The source cohort included consecutive patien...

Full description

Bibliographic Details
Main Authors: Johan Isaksson, Leo Wennström, Eva Branden, Hirsh Koyi, Anders Berglund, Patrick Micke, Johanna Sofia Margareta Mattsson, Linda Willén, Johan Botling
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Lung cancer
Inflammation
NSCLC
Survival
C-reactive protein
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294222000466

Internet

http://www.sciencedirect.com/science/article/pii/S2468294222000466

Similar Items